USE OF THE ELEVATED PLUS-MAZE IN THE SEARCH FOR NOVEL ANXIOLYTIC AGENTS

被引：444

作者：

DAWSON, GR

TRICKLEBANK, MD

机构：

[1] Merck, Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, CM20 2QR, Terlings Park, Eastwick Road

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1995年 / 16卷 / 02期

关键词：

D O I：

10.1016/S0165-6147(00)88973-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

收藏

页码：33 / 36

页数：4

相关论文

共 17 条

[1] COLE JC, 1993, BEHAV PHARMACOL, V4, P573
[2] ETHOLOGICAL EVALUATION OF THE EFFECTS OF ACUTE AND CHRONIC BUSPIRONE TREATMENT IN THE MURINE ELEVATED PLUS-MAZE TEST - COMPARISON WITH HALOPERIDOL
COLE, JC
RODGERS, RJ
[J]. PSYCHOPHARMACOLOGY, 1994, 114 (02) : 288 - 296
[3] DAWSON G, IN PRESS PSYCHOPHARM
[4] ONE-TRIAL TOLERANCE TO THE EFFECTS OF CHLORDIAZEPOXIDE ON THE ELEVATED PLUS-MAZE MAY BE DUE TO LOCOMOTOR HABITUATION, NOT REPEATED DRUG EXPOSURE
DAWSON, GR
CRAWFORD, SP
STANHOPE, KJ
IVERSEN, SD
TRICKLEBANK, MD
[J]. PSYCHOPHARMACOLOGY, 1994, 113 (3-4) : 570 - 572
[5] FALTER U, 1992, BEHAV PHARMACOL, V3, P123
[6] BEWARE THE BUILDERS - CONSTRUCTION NOISE CHANGES [C-14] GABA RELEASE AND UPTAKE FROM AMYGDALOID AND HIPPOCAMPAL SLICES IN THE RAT
FERNANDES, C
FILE, SE
[J]. NEUROPHARMACOLOGY, 1993, 32 (12) : 1333 - 1336
[7] TRIAL 2 IN THE ELEVATED PLUS-MAZE - A DIFFERENT FORM OF FEAR
FILE, SE
ZANGROSSI, H
VIANA, M
GRAEFF, FG
[J]. PSYCHOPHARMACOLOGY, 1993, 111 (04) : 491 - 494
[8] AN ASSESSMENT OF THE ELEVATED X-MAZE FOR STUDYING ANXIETY AND ANXIETY-MODULATING DRUGS
HANDLEY, SL
MCBLANE, JW
[J]. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1993, 29 (03) : 129 - 138
[9] Lister R.G., 1991, PSYCHOPHARMACOLOGY A, P155, DOI [10.1016/b978-0-08-040698-5.50012-0, DOI 10.1016/B978-0-08-040698-5.50012-0]
[10] LUSCOMBE GP, 1992, BRIT J PHARMACOL, V105, pP221